(PEB) Pebblebrook Hotel Trust - Overview
Sector: Real Estate | Industry: REIT - Hotel & Motel | Exchange: NYSE (USA) | Market Cap: 1.594m USD | Total Return: 55.6% in 12m
Industry Rotation: +10.6
Avg Turnover: 27.3M
EPS Trend: -21.1%
Qual. Beats: 0
Rev. Trend: -67.1%
Qual. Beats: 2
Warnings
High Debt/EBITDA (7.8) with thin interest coverage (0.6)
Interest Coverage Ratio 0.6 is critical
Altman Z'' -2.04 < 1.0 - financial distress zone
Tailwinds
Supp Ema20, Confidence
Pebblebrook Hotel Trust (NYSE: PEB) is a real estate investment trust (REIT) focused on the ownership of urban and resort lifestyle hotels within the United States. The company’s portfolio includes 44 properties comprising approximately 11,000 guest rooms distributed across 13 major domestic markets.
As a Hotel REIT, the company’s business model relies on generating revenue through room rentals and ancillary services while benefiting from the tax advantages associated with the REIT structure, which requires distributing at least 90% of taxable income to shareholders. The lifestyle segment specifically targets high-margin travelers by emphasizing unique design and localized guest experiences rather than standardized branding.
Investors can evaluate the underlying asset valuations and historical performance trends of this trust by reviewing the data on ValueRay. The company maintains a geographic concentration in coastal gateway cities and prominent vacation destinations to capture both business and leisure demand cycles.
- Urban business travel recovery directly impacts RevPAR growth in key coastal markets
- High interest rates increase debt service costs for variable-rate hotel financing
- Strategic disposition of non-core assets drives capital recycling and share buybacks
- Leisure demand volatility at high-end resorts influences quarterly earnings performance
- Labor cost inflation in major metropolitan areas compresses property-level operating margins
| Net Income: -52.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.57 > 1.0 |
| NWC/Revenue: -31.71% < 20% (prev -7.66%; Δ -24.05% < -1%) |
| CFO/TA 0.05 > 3% & CFO 283.4m > Net Income -52.1m |
| Net Debt (2.22b) to EBITDA (282.4m): 7.85 < 3 |
| Current Ratio: 0.34 > 1.5 & < 3 |
| Outstanding Shares: last quarter (113.3m) vs 12m ago -4.93% < -2% |
| Gross Margin: 17.85% > 18% (prev 0.25%; Δ 1.76k% > 0.5%) |
| Asset Turnover: 27.40% > 50% (prev 25.83%; Δ 1.57% > 0%) |
| Interest Coverage Ratio: 0.62 > 6 (EBITDA TTM 282.4m / Interest Expense TTM 97.4m) |
| A: -0.09 (Total Current Assets 244.3m - Total Current Liabilities 720.3m) / Total Assets 5.30b |
| B: -0.29 (Retained Earnings -1.53b / Total Assets 5.30b) |
| C: 0.01 (EBIT TTM 60.3m / Avg Total Assets 5.48b) |
| D: -0.55 (Book Value of Equity -1.53b / Total Liabilities 2.77b) |
| Altman-Z'' Score: -2.04 = D |
| DSRI: 0.89 (Receivables 39.7m/43.2m, Revenue 1.50b/1.46b) |
| GMI: 1.38 (GM 17.85% / 24.69%) |
| AQI: 0.55 (AQ_t 0.01 / AQ_t-1 0.01) |
| SGI: 1.03 (Revenue 1.50b / 1.46b) |
| TATA: -0.06 (NI -52.1m - CFO 283.4m) / TA 5.30b) |
| Beneish M-Score: -3.08 (Cap -4..+1) = AA |
Over the past week, the price has changed by +4.41%, over one month by +5.51%, over three months by +17.75% and over the past year by +55.59%.
- StrongBuy: 2
- Buy: 1
- Hold: 8
- Sell: 1
- StrongSell: 2
| Analysts Target Price | 14.4 | -3.9% |
P/S = 1.062
P/B = 0.6848
P/EG = 3.2069
Revenue TTM = 1.50b USD
EBIT TTM = 60.3m USD
EBITDA TTM = 282.4m USD
Long Term Debt = 1.72b USD (from longTermDebt, last quarter)
Short Term Debt = 360.0m USD (from shortTermDebt, last quarter)
Debt = 2.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.22b USD (from netDebt column, last quarter)
Enterprise Value = 3.81b USD (1.59b + Debt 2.41b - CCE 196.2m)
Interest Coverage Ratio = 0.62 (Ebit TTM 60.3m / Interest Expense TTM 97.4m)
EV/FCF = 14.84x (Enterprise Value 3.81b / FCF TTM 256.8m)
FCF Yield = 6.74% (FCF TTM 256.8m / Enterprise Value 3.81b)
FCF Margin = 17.11% (FCF TTM 256.8m / Revenue TTM 1.50b)
Net Margin = -3.47% (Net Income TTM -52.1m / Revenue TTM 1.50b)
Gross Margin = 17.85% ((Revenue TTM 1.50b - Cost of Revenue TTM 1.23b) / Revenue TTM)
Gross Margin QoQ = 23.37% (prev -10.59%)
Tobins Q-Ratio = 0.72 (Enterprise Value 3.81b / Total Assets 5.30b)
Interest Expense / Debt = 0.96% (Interest Expense 23.1m / Debt 2.41b)
Taxrate = 21.0% (US default 21%)
NOPAT = 47.6m (EBIT 60.3m * (1 - 21.00%))
Current Ratio = 0.34 (Total Current Assets 244.3m / Total Current Liabilities 720.3m)
Debt / Equity = 0.99 (Debt 2.41b / totalStockholderEquity, last quarter 2.44b)
Debt / EBITDA = 7.85 (Net Debt 2.22b / EBITDA 282.4m)
Debt / FCF = 8.63 (Net Debt 2.22b / FCF TTM 256.8m)
Total Stockholder Equity = 2.51b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.95% (Net Income -52.1m / Total Assets 5.30b)
RoE = -2.07% (Net Income TTM -52.1m / Total Stockholder Equity 2.51b)
RoCE = 1.42% (EBIT 60.3m / Capital Employed (Equity 2.51b + L.T.Debt 1.72b))
RoIC = 1.02% (NOPAT 47.6m / Invested Capital 4.69b)
WACC = 4.77% (E(1.59b)/V(4.01b) * Re(10.84%) + D(2.41b)/V(4.01b) * Rd(0.96%) * (1-Tc(0.21)))
Discount Rate = 10.84% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.22 | Cagr: -3.16%
[DCF] Terminal Value 86.71% ; FCFF base≈298.9m ; Y1≈310.5m ; Y5≈355.6m
[DCF] Fair Price = 73.26 (EV 10.52b - Net Debt 2.22b = Equity 8.31b / Shares 113.4m; r=6.0% [WACC]; 5y FCF grow 4.08% → 3.0% )
EPS Correlation: -21.09 | EPS CAGR: -16.51% | SUE: 0.68 | # QB: 0
Revenue Correlation: -67.14 | Revenue CAGR: -84.73% | SUE: 4.0 | # QB: 2
EPS current Quarter (2026-06-30): EPS=0.10 | Chg30d=+75.00% | Revisions=N/A | Analysts=2
EPS next Quarter (2026-09-30): EPS=0.03 | Chg30d=N/A | Revisions=N/A | Analysts=2
EPS current Year (2026-12-31): EPS=-0.56 | Chg30d=+3.99% | Revisions=N/A | GrowthEPS=-26.0% | GrowthRev=-0.2%
EPS next Year (2027-12-31): EPS=-0.36 | Chg30d=+33.11% | Revisions=-20% | GrowthEPS=+36.3% | GrowthRev=+1.4%
[Analyst] Revisions Ratio: -20%